Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
Vincent Mallet, K Böck, Mourad Dellagi, Marion Tano et autres
fr, be (code pays fourni par la source)
9 citations
Journal of Hepatology